Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance

CardioVascular and Interventional Radiology

Volumn 34, Issue SUPPL. 2, 2011, Pages

  Schoellnast, Helmut ^a,b   Larson, Steven M ^a   Nehmeh, Sadek A ^a   Carrasquillo, Jorge A ^a   Thornton, Raymond H ^a   Solomon, Stephen B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

FDG PET; Monitoring; Positron emission tomography; Radiofrequency ablation; RFA; Tumor ablation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG BIOPSY; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TUMOR VOLUME;

AGED; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; REOPERATION; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79959705832     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-9898-7     Document Type: Article

References (10)

1. Kelekis AD, Thanos L, Mylona S et al (2006) Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: current status. Eur Radiol 16:2471-2482 (Pubitemid 44649696)
2. Higaki F, Okumura Y, Sato S et al (2008) Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor. Ann Nucl Med 22:157-163 (Pubitemid 351729622)
3. Larson SM, Erdi Y, Akhurst T et al (1999) Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis. Clin Positron Imag 2:159-171
4. Akhurst T, Downey R, Ginsberg M et al (2002) An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 73:259-264
5. Okuma T, Matsuoka T, Okamura T et al (2006) 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47:1351-1358 (Pubitemid 47544891)
6. Basu S, Kung J, Houseni M et al (2009) Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions. Q J Nucl Med Mol Imag 53:9-19
7. Matthies A, Hickeson M, Cuchiara A, Alavi A (2002) Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 43:871-875 (Pubitemid 34747808)
8. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42:1412-1417
9. Hataji O, Yamakado K, Nakatsuka A et al (2005) Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation. Intern Med 44:865-869 (Pubitemid 41263836)
10. 15O-water PET imaging. J Nucl Med 49:1723-1729